REFERENCES
1. Parish LC. An historical approach to the nomenclature of rheumatoid arthritis. Arthritis Rheum 1963;6:138–158.
2. Benedek TG. When did “osteo-arthritis” become osteoarthritis? J Rheumatol 1999;26:1374–1376.
3. Keuttner KE, Goldberg V, eds. Osteoarthritic disorders. Rosemont, IL: American Academy of Orthopedic Surgeons 1995:21–25.
4. Sokoloff L. Osteoarthritis as a remodeling process. J Rheumatol 1987; 14[Suppl 14]:7–10.
5. Hough AJ. Pathology of osteoarthritis. In: Koopman WJ, ed. Arthritis and allied conditions, 14th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:2167–2194.
6. Blanco FJ, Guitian R, Vasquez-Martul E, et al. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis. Arthritis Rheum 1998;41:284–289.
7. Hashimoto S, Ochs RL, Komiya S, et al. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 1998;41:1632–1638.
8. Rosenberg ZS, Shankman S, Steiner GC, et al. Rapidly destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology 1992;182:213–216.
9. Yamamoto T, Yamaguchi T, Lee KB, et al. A clinicopathologic study of osteonecrosis in the osteoarthritic hip. Osteoarthritis Cartilage 2000;8:303–308.
10. Soren A, Cooper NS, Waugh TR. The nature and designation of osteoarthritis determined by its histopathology. Clin Exp Rheumatol 1988; 6:41–46.
11. Malemud CJ, Goldberg VM, Moskowitz RW. Pathological, biochemical, and experimental therapeutic studies in meniscectomy models of osteoarthritis in the rabbits: relationship to human joint pathology. Br J Clin Pract 1986;43[Suppl]:21–31.
12. Dedrick DK, Goldstein SA, Brandt KD, et al. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up to 54 months. Arthritis Rheum 1993; 36:1460–1467.
13. Messner K, Fahlgren A, Ross I, et al. Simultaneous changes in bone mineral density and articular cartilage in a rabbit meniscectomy model of knee osteoarthrosis. Osteoarthritis Cartilage 2000;8:197–206.
14. Bullough PG, Jagannath A. The morphology of the calcification front in articular cartilage. J Bone Joint Surg Br 1983;65B:72–78.
15. Clark JM, Huber JD. The structure of the human subchondral plate. J Bone Joint Surg 1990;72B:866–873.
16. Oegema TR, Carpenter RJ, Hofmeister F, et al. The interaction of the zone of calcified cartilage and subchondral bone in osteoarthritis. Microsc Res Tech 1997;37:324–332.
17. Mori S, Haruff R, Burr DB. Microcracks in the articular cartilage of human femoral heads. Arch Pathol Lab Med 1993;117:196–198.
18. Sokoloff L. Microcracks in the calcified layer of articular cartilage. Arch Pathol Lab Med 1993;117:191–195.
19. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986;213:34–40.
20. Koszyca B, Fazzalari NL, Vernon-Roberts B. Microfractures in coxarthrosis. Acta Orthop Scand 1990;61:307–310.
21. Fazzalari NL, Parkinson IH. Fractal properties of subchondral cancellous bone in severe osteoarthritis of the hip. J Bone Miner Res 1997; 12:632–640.
22. Fazzalari NL, Vernon-Roberts B, Darracott J. Osteoarthritis of the hip. Possible protective and causative roles of trabecular microfractures in the head of the femur. Clin Orthop 1987;216:224–233.
23. Moore RJ, Fazzalari NL, Manthey BA, et al. The relationship between head-neck-shaft angle, calcar width, articular cartilage thickness and bone volume in arthrosis of the hip. Br J Rheumatol 1994;33:432–436.
24. Arokoski JP, Arokoski MH, Jurvelin JS, et al. Increased bone mineral content and bone size in the femoral neck of men with his osteoarthritis. Ann Rheum Dis 2002;61:145–150.
25. Fazzalari NL, Parkinson, IH. Femoral trabecular bone of osteoarthritic and normal subjects in an age and sex matched group. Osteoarthritis Cartilage 1998;6:377–382.
26. Fazzalari NL, Kuliwaba JS, Forwood, MR. Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution. Bone 2002;31:697–702.
27. Fazzalari NL, Moore RJ, Manthey BA, et al. Comparative study of iliac crest and subchondral bone in osteoarthritic patients. Bone 1992; 13:331–335.
28. Schnitzler CM, Mesquita JM, Wane L. Bone histomorphometry of the iliac crest and spinal fracture prevalence in atrophic and hypertrophic osteoarthritis of the hip. Osteoporosis Int 1992;2:186–194.
29. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889–895.
30. Malinin T, Ouelette EA. Articular cartilage nutrition is mediated by subchondral bone: a long-term autograft study in baboons. Osteoarthritis Cartilage 2000;8:483–491.
31. Brandt KD, Myers SL, Burr D, et al. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 1991;34:1560–1570.
32. Bennett GA, Waine H, Bauer W. Changes in the knee joint at various ages. New York: Commonwealth Fund, 1942.
33. Ohno O, Naito J, Iguchi T, et al. An electron microscopic study of early pathology in chondromalacia of the patella. J Bone Joint Surg Am 1988;70A:883–899.
34. Mori Y, Kubo M, Okumo H, et al. Histological comparison of patellar cartilage degeneration between chondromalacia in youth and osteoarthritis in aging. Knee Surg Sports Traumatol Arthrosc 1995;3:167–172.
35. Jensen DB, Albrektsen SB. The natural history of chondromalacia patellae. A 12-year follow-up. Acta Orthop Belg 1990;56:503–506.
36. Cs-Szabo G, Melching LI, Rhoughley PJ, et al. Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum 1997;40:1037–1045.
37. Walter H, Kawashima A, Nebelung W, et al. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol Res Pract 1998;194:73–81.
38. Tetlow LC, Adlam DJ, Wooley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585–594.
39. Masuhara K, Nakai T, Yamaguchi K, et al. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum 2002;46:2625–2631.
40. Lohmander LS, Lark MW, Dahlberg L, et al. Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin Biochem 1992;25:167–174.
41. Pap G, Eberhardt R, Rocken C, et al. Expression of stromelysin and urokinase type plasminogen activator protein in resection specimens and biopsies at different stages of osteoarthritis of the knee. Pathol Res Pract 2000;196:219–226.
42. Pitsillides AA, Will RK, Bayliss MT, et al. Circulating and synovial fluid hyaluronan levels. Arthritis Rheum 1994;37:1030–1038.
43. Murphy E, FitzGerald O, Saxne T, Bresnihan B. Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae. Ann Rheum Dis 2002;61:981–985.
44. Lee DA, Bentley G, Archer CW. The control of cell division in articular chondrocytes. Osteoarthritis Cartilage 1993;1:137–146.
45. Poole CA, Matsuoka A, Schofield JR. Chondrons from articular cartilage III. Morphologic changes in the cellular microenvironment of chondrons isolated from osteoarthritic cartilage. Arthritis Rheum 1991; 34:22–35.
46. Rotzer A, Mohr W. 3H-thymidine incorporation into chondrocytes of arthritic cartilage [in German]. Z Rheumatol 1992;51:172–176.
47. Macha N, Older J, Bitensky L, et al. Abnormalities of DNA in human osteoarthritic articular cartilage. Cell Biochem Funct 1993;11:63–69.
48. Dahlen A, Broberg K, Domanski HA, et al. Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis. Cancer Genet Cytogenet 2001;131:19–24.
49. Kusuzaki K, Sugimoto S, Takeshita H, et al. DNA cytofluorometric analysis of chondrocytes in human articular cartilages under normal aging or arthritic conditions. Osteoarthritis Cartilage 2001;9:664–670.
50. Alaaedine N, Olee T, Hashimoto S, et al. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001;44:1633–1643.
51. Honorati MC, Bovara M, Cattini L, et al. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 2002;10:799–807.
52. Martel-Pelletier J, McCollum R, DiBattista J, et al. The interleukin-I receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 1992;35:530–540.
53. Aigner T, Hemmel M, Neureiter D, et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 2001;44:1304–1312.
54. Han B, Cole AA, Shen Y, et al. Early alterations in the collagen meshwork and lesions in the ankles are associated with spontaneous osteoarthritis in guinea-pigs. Osteoarthritis Cartilage 2002;10:778–784.
55. Kim HA, Lee YJ, Seong SC, et al. Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 2000;27:455–462.
56. Kouri JB, Aguilera JM, Reyes J, et al. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000;27:1005–1019.
57. Matsuo M, Nishida K, Yoshida A, et al. Expression of caspase-3 and -9 relevant to cartilage destruction and chondrocyte apoptosis in human osteoarthritic cartilage. Acta Med Okayama 2001;55:333–340.
58. Yatsugi N, Tsukazaki T, Osaki M, et al. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci 2000;5: 150–156.
59. Hashimoto S, Ochs RL, Komiya S, et al. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 1998;41:1632–1638.
60. Hashimoto S, Ochs RL, Rosen F, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 1998;95:3094–3099.
61. Doi T, Nishida K, Matsuo M, et al. Evidence of oncotic cell death and DNA fragmentation in human hypertrophic chondrocytes in chondro-osteophyte. Osteoarthritis Cartilage 2002;10:270–276.
62. Sokoloff L, DiFrancesco L. Lipochondral degeneration of capsular tissue in osteoarthritic hips. Am J Surg Pathol 1995;19:278–283.
63. Wittenberg RH, Willburger RE, Kleemeyer KS, et al. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 1993;36:1444–1450.
64. David MJ, Portoukalian J, Rebbaa A, et al. Characterization of gangliosides from normal and osteoarthritic human articular cartilage. Arthritis Rheum 1993;36:938–942.
65. Aspden RM, Scheven BA, Hutchinson JD. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001;357:1118–1120.
66. Murphy JM, Dixon K, Beck S, et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002;46:704–713.
67. Ghadially FN, Lalonde JM, Yong NK. Ultrastructure of amianthoid fibers in osteoarthritic cartilage. Virchows Arch [B] 1979;31: 81–86.
68. Curtin WA, Reville WJ. Ultrastructural observations on fibril profiles in normal and degenerative human articular cartilage. Clin Orthop 1995;313:224–230.
69. Gannon FH, Sokoloff L. Histomorphometry of the aging human patella: histologic criteria and controls. Osteoarthritis Cartilage 1999;7:173–181.
70. Lafeber FP, Van der Kraan PM, Van Roy HL, et al. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am J Pathol 1992;140:1421–1429.
71. Tsuchiya K, Maloney WJ, Vu T, et al. Osteoarthritis: differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage. J Orthop Res 1997;15:94–100.
72. Shlopov BV, Lie WR, Mainard CL, et al. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40: 2065–2074.
73. Imai K, Ohta S, Matsumoto T, et al. Expression of matrix metallo-proteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997;151:245–256.
74. Soder S, Hambach L, Lissner R, et al. Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. Osteoarthritis Cartilage 2002;10:464–70.
75. Price JS, Till SH, Bickerstaff DR, et al. Degradation of cartilage type II collagen precedes the onset of osteoarthritis following anterior cruciate ligament rupture. Arthritis Rheum 1999;42:2390–2398.
76. Aigner T, Bertling W, Stoss H, et al. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993;91:829–837.
77. Misoge N, Waletzko K, Bode C, et al. Light and electron microscopic in situ hybridization of collagen type I and type II mRNA in the fibrocartilaginous tissue of late-stage osteoarthritis. Osteoarthritis Cartilage 1998;6:278–285.
78. Walker GD, Fischer M, Gannon J, et al. Expression of type-X collagen in osteoarthritis. J Orthop Res 1995;13:4–12.
79. Gibson GJ, Verner JJ, Nelson FR, Lin DL. Degradation of the cartilage collagen matrix associated with changes in chondrocytes in osteoarthrosis. Assessment by loss of background fluorescence and immunodetection of matrix components. J Orthop Res 2001;19: 33–42.
80. Gebhard PM, Gehrsitz A, Bau B, et al. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J Orthop Res 2003;21:96–101.
81. Aigner T, Vornehm SI, Zeiler G, et al. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum 1997;40:562–569.
82. Amir G, Pirie CJ, Rashad S, et al. Remodelling of subchondral bone in osteoarthritis: a histomorphometric study. J Clin Pathol 1992;45: 990–992.
83. Derfus B, Kranendonk S, Camacho N, et al. Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998;63:258–262.
84. Nanba Y, Nishida K, Yoshikawa T, et al. Expression of osteonectin in articular cartilage of osteoarthritic knees. Acta Med Okayama 1997; 51:239–243.
85. Pullig O, Weseloh G, Gauer S, et al. Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 2000;19:245–255.
86. Burr DB, Schaffler MB. The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence. Microsc Res Tech 1997;37:343–351.
87. Kamibayashi L, Wyss UP, Cooke TD, et al. Trabecular microstructure in the medial condyle of the proximal tibia of patients with knee osteoarthritis. Bone 1995;17:27–35.
88. Sabokbar A, Crawford R, Murray DW, et al. Macrophage-osteoclast differentiation and bone resorption in osteoarthrotic subchondral acetabular cysts. Acta Orthop Scand 2000;71:255–261.
89. Arlet J, Laroche M, Soler R, et al. Histopathology of the vessels of the femoral heads in specimens of osteonecrosis, osteoarthritis, and algodystrophy. Clin Rheumatol 1993;12:162–165.
90. Franchi A, Bullough PG. Secondary avascular necrosis in coxarthrosis: a morphologic study. J Rheumatol 1992;19:1263–1268.
91. Calder JD, Pearse MF, Revell PA. The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br 2001;83:419–422.
92. Cheras PA, Whitaker AN, Blackwell EA, et al. Hypercoagulability and hypofibrinolysis in primary osteoarthritis. Clin Orthop 1997; 334:57–67.
93. Ryu KN, Kim EJ, Yoo MC, et al. Ischemic necrosis of the entire femoral head and rapidly destructive hip disease: potential causative relationship. Skeletal Radiol 1997;26:143–149.
94. O’Connell JT, Nielsen GP, Rosenberg AE. Subchondral acute inflammation in severe arthritis: a sterile osteomyelitis? Am J Surg Pathol 1999;23:192–197.
95. Yamamoto T, Bullough PG. Subchondral insufficiency fracture of the femoral head: a differential diagnosis in acute onset of coxarthrosis in the elderly. Arthritis Rheum 1999;42:2719–2723.
96. Yamamoto T, Schneider R, Bullough PG. Insufficiency subchondral fracture of the femoral head. Am J Surg Pathol 2000;24:464–468.
97. Pritzker KPH. Articular-skeletal system: muscle, fat, and other connective tissues. In: Kovacs K, Asa SL, eds. Functional endocrine pathology, 2nd ed. Oxford: Blackwell, 1998:766–769.
98. Pereira ER, Brown RR, Resnick D. Prevalence and patterns of tendon calcifications in patients with chondrocalcinosis of the knee: radiographic study of 156 patients. Clin Imaging 1998;22:371–375.
99. Sokoloff L, Varma AA. Chondrocalcinosis in surgically resected joints. Arthritis Rheum 1988:750–756.
100. Derfus BA, Kurian JB, Butler JJ, et al. The high prevalence of pathologic calcium crystals in preoperative knees. J Rheumatol 2002;29: 570–574.
101. Habata T, Ohgushi H, Takakura Y, et al. Relationship between meniscal degeneration and element contents. Biol Trace Elem Res 2001;79: 247–256.
102. Hough AJ, Webber RJ. The pathology of the meniscus. Clin Orthop 1990;252:32–40.
103. Pritzker KP, Cheng PT, Renlund RC. Calcium pyrophosphate crystal deposition in hyaline cartilage: ultrastructural analysis and implications for pathogenesis. J Rheumatol 1988;15:828–835.
104. Cardenal A, Masuda I, Ono W, et al. Serum nucleotide pyrophosphatase activity: elevated levels in osteoarthritis, calcium pyrophosphate crystal deposition disease, scleroderma, and fibromyalgia. J Rheumatol 1998;25:2175–2180.
105. Swan A, Chapman B, Heap P, et al. Submicroscopic crystals in osteoarthritic synovial fluids. Ann Rheum Dis 1994;53:467–470.
106. Schulte E, Fisseler-Eckhoff A, Muller KM. [Differential diagnosis of synovitis. Correlation of arthroscopic-biopsy to clinical findings]. Pathologie 1994;15:22–27.
107. Oehler S, Neureiter D, Meyer-Scholten C, et al. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol;2002:20:633–640.
108. Baeten D, Demetter P, Cuvelier C, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 2000;59:945–953.
109. Ezawa K, Yamamura M, Matsui H, et al. Comparative analysis of CD45RA- and CD45RO-positive CD4+ T cells in peripheral blood, synovial fluid and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Acta Med Okayama 1997;51:25–31.
110. Haynes MK, Hume EL, Smith JB. Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 2002;105:315–325.
111. Fort JG, Flanigan M, Smith JB. Mononuclear cell (MNC) subtypes in osteoarthritis synovial fluid. J Rheumatol 1995;22:1335–1337.
112. Kummer JA, Tak PP, Brinkman BM, et al. Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 1994;73:88–95.
113. Dean G, Hoyland JA, Denton J, et al. Mast cells in the synovium and synovial fluid in osteoarthritis. Br J Rheumatol 1993;32:671–675.
114. Pu J, Nishida K, Inoue H, et al. Mast cells in osteoarthritic and rheumatoid arthritic synovial tissues of the human knee. Acta Med Okayama 1998;52:35–39.
115. Buckley MG, Gallagher PJ, Walls AF. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells. J Pathol 1998;186:67–74.
116. Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723–733.
117. Myers SL, Flusser D, Brandt KD, et al. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis. J Rheumatol 1992;19:1247–1251.
118. Dodds RA, Connor JR, Drake FH, et al. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum 1999;42:1588–1593.
119. Smith MD, Triantafillou S, Parker A, et al. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365–371.
120. Pitsillides AA, Will RK, Bayliss MT, et al. Circulating and synovial fluid hyaluronan levels. Effects of intraarticular corticosteroid on the concentration and the rate of turnover. Arthritis Rheum 1994;37: 1030–1038.
121. Stamenkovic I, Stegagno M, Wright KA, et al. Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A 1988;85:1179–1183.
122. Guerassimov A, Zhang Y, Cartman A, et al. Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis. Arthritis Rheum 1999;42:527–533.
123. Vetto AA, Mannik M, Zatarain-Rios E, et al. Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol Int 1990;10:13–20.
124. Hopkinson ND, Powell RJ, Doherty M. Autoantibodies, immunoglobulins, and Gm allotypes in nodal generalized osteoarthritis. Br J Rheumatol 1992;31:605–608.
125. Webb GR, Westacott CI, Elson CJ. Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 1997;5:427–437.
126. Roos EM, Ostenberg A, Roos H, et al. Long-term outcome of meniscectomy: symptoms, function, and performance tests in patients with or without radiographic osteoarthritis compared to matched controls. Osteoarthritis Cartilage 2001;9:316–324.
127. Bhattacharyya T, Gale D, Dewire P, et al. The clinical importance of meniscal tears demonstrated by magnetic resonance imaging in osteoarthritis of the knee. J Bone Joint Surg Am 2003;85-A:4–9.
128. Englund M, Roos EM, Roos HP, et al. Patient-relevant outcomes fourteen years after meniscectomy: influence of type of meniscal tear and size of resection. Rheumatology (Oxford) 2001;40:631–639.
129. Doherty M, Watt I, Dieppe PA. Influence of primary generalized osteoarthritis on development of secondary osteoarthritis. Lancet 1983; 2:8–11.
130. Croft P, Cooper C, Wickham C, et al. Is the hip involved in generalized osteoarthritis? Br J Rheumatol 1992;31:325–328.
131. Ladefoged C, Merrild V, Jorgensen B. Amyloid deposits in surgically removed articular and periarticular tissue. Histopathology 1989;15: 289–296.
132. Ray A, Kuroki K, Cook JL, et al. Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum 2003; 48:134–145.
133. Wada T, Miyata T, Sakai H, et al. Beta-2-microglobulin and renal bone disease. Perit Dial Int 1999;19[Suppl 2]:S413–416.
134. Nelson F, Dahlberg L, Laverty S, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998; 102:2115–2125.
135. Gelse K, Soder S, Eger W, et al. Osteophyte development-molecular characterization of differentiation stages. Osteoarthritis Cartilage 2003;11:141–148.
136. Rothschild B, Helbling M, Miles C. Spondyloarthropathy in the Jurassic. Lancet 2002;360(9344):1454.
137. Kolmstetter C, Munson L, Ramsay EC. Degenerative spinal disease in large fields. J Zoo Wildl Med 2000;31:15–19.
138. Anderson-Mackenzie JM, Hulmes DJ, Thorp BH. Degenerative joint disease in poultry-differences in composition and morphology of articular cartilage are associated with strain susceptibility. Res Vet Sci 1997;63:29–33.
139. Glasson SS, Trubetskoy OV, Harlan PM, et al. Blotchy mice: a model of osteoarthritis associated with a metabolic defect. Osteoarthritis Cartilage 1996;4:209–212.
140. Saamanen AK, Salminen HJ, Dean PB, et al. Osteoarthritis-like lesions in transgenic mice harboring a small deletion mutation in type II collagen gene. Osteoarthritis Cartilage 2000;8:248–257.
141. Das-Gupta EP, Lyons TJ, Hoyland JA, et al. New histological observations in spontaneously developing osteoarthritis in the STR/ORT mouse questioning its acceptability. Int J Exp Pathol 1993;74:627–634.
142. Munasinghe JP, Tyler JA, Hodgson RJ, et al. Magnetic resonance imaging, histology, and X-ray of three stages of damage to the knees of STR/ORT mice. Invest Radiol 1996;31:630–638.
143. Brewster M, Lewis EJ, Wilson KL, et al. Ro 32–3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis. Arthritis Rheum 1998;41: 1639–1644.
144. Collins C, Evans RG, Ponsford F, et al. Chondro-osseous metaplasia, bone density and patellar cartilage proteoglycan content in the osteoarthritis of STR/ORT mice. Osteoarthritis Cartilage 1994;2:111–118.
145. Huebner JL, Hanes MA, Beekman B, et al. A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage 2002;10:758–767.
146. Jimenez PA, Glasson SS, Truketskoy OV, et al. Spontaneous osteoarthritis in Dunkin-Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim Sci 1997;47:598–601.
147. Moskowitz RW, Ziv I, Denko CW, et al. Spondylosis in sand rats: a model of intervertebral disc degeneration and hyperostosis. J Orthop Res 1990;8:401–411.
148. Ohlerth S, Busato A, Gaillard C, et al. [Epidemiologic and genetic studies of canine hip dysplasia in a population of Labrador retrievers: a study over 25 years]. Dtsch Tierarztl Wochenschr 1998;105:378–383.
149. Lust G. An overview of the pathogenesis of canine hip dysplasia. J Am Vet Med Assoc 1997;210:1443–1445.
150. Smith MM, Ghosh P. Experimental models of osteoarthritis. In: Moskowitz RW, Howell DS, Altman RD, et al., eds. Osteoarthritis: diagnosis and medical/surgical management, 3rd ed. Philadelphia: WB Saunders, 2001:171–199.
151. Fernandes JC, Jovanovic D, Dehnade F, et al. [Resection of the anterior cruciate ligament of the knee using arthroscopy induces arthrosis in dogs. Validity of the Pond-Nuki model]. Ann Chir 1998;52:768–775.
152. Chang DG, Iverson EP, Schinagl RM, et al. Quantitation and localization of cartilage degeneration following the induction of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage 1997;5:357–372.
153. Hashimoto S, Takahashi K, Amiel D, et al. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41:1266–1274.
154. Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 1999; 154:1159–1169.
155. Janusz MJ, Bendele AM, Brown KK, et al. Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cartilage 2002;10:785–791.
156. Panula HE, Lohmander LS, Ronkko S, et al. Elevated levels of synovial fluid PLA 2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta Orthop Scand 1998;69:152–158.
157. Panula HE, Hyttinen MM, Arokoshi JP, et al. Articular cartilage superficial zone collagen birefringence reduced and cartilage thickness increased before surface fibrillation in experimental osteoarthritis. Ann Rheum Dis 1998;57:237–245.
158. Buckwalter JA. Osteoarthritis and articular cartilage use, disuse, and abuse: experimental studies. J Rheumatol 1995;43[Suppl]:13–15.
159. Lundy DW, Ganey TM, Ogden JA, et al. Pathologic morphology of the dislocated proximal femur in children with cerebral palsy. J Pediatr Orthop 1998;18:528–534.
160. Salo, PT, Hogervorst T, Seerattan RA, et al. Selective joint denervation promotes knee osteoarthritis in the aging rat. J Orthop Res 2002;20:1256–1264.
161. Farquhar T, Xia Y, Mann K, et al. Swelling and fibronectin accumulation in articular cartilage explants after cyclical impact. J Orthop Res 1996;14:417–423.
162. Van Osch GJ, van der Kraan PM, van Valburg AA, et al. The relation between cartilage damage and osteophyte size in a murine model for osteoarthritis in the knee. Rheumatol Int 1996;16:115–119.
163. Panula HE, Helminen HJ, Kiviranta I. Slowly progressive osteoarthritis after tibial valgus osteotomy in young beagle dogs. Clin Orthop 1997;343:192–202.
164. Bishop PB, Pearce RH. The proteoglycans of the cartilaginous end-plate of the human intervertebral disc change after maturity. J Orthop Res 1993;11:324–331.
165. Vernon-Roberts B, Fazzalari NL, Manthey BA. Pathogenesis of tears of the anulus investigated by multiple-level transaxial analysis of the T12-L1 disc. Spine 1997;22:2641–2646.
166. Heggeness MH, Doherty BJ. Morphologic study of lumbar vertebral osteophytes. South Med J 1998;91:187–189.
167. O’Neill TW, McCloskey EV, Kanis JA, et al. The distribution, determinants, and clinical correlates of vertebral osteophytosis: population based survey. J Rheumatol 1999;26:842–848.
168. von der Recke P, Hansen MA, Overgaard K, et al. The impact of degenerative conditions in the spine on bone mineral density and fracture prediction. Osteoporos Int 1996;6:43–49.
169. Miyakoshi N, Itoi E, Murai H, et al. Inverse relationship between osteoporosis and spondylosis in postmenopausal women as evaluated by bone mineral density and semiquantitative scoring of spinal degeneration. Spine 2003;28:492–495.
170. Liu G, Peacock M, Eilam O, et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 1997;7:564–569.
171. Marcelli C, Favier F, Kotzki PO, et al. The relationship between osteoarthritis of the hands, bone mineral density, and osteoporotic fractures in elderly women. Osteoporos Int 1995;5:382–388.
172. Tanaka N, Tsuchiya T, Shiokawa A, et al. [Histopathological studies of the osteophytes and ossification of the posterior longitudinal ligament (OPLL) in the cervical spine]. Nippon Seikeigeka Gakkai Zasshi 1996;60:323–336.
173. Scutellari PN, Orzincolo C, Princivalle M, et al. [Diffuse idiopathic skeletal hyperostosis. Review of diagnostic criteria and analysis of 915 cases]. Radiol Med (Torino) 1992;83:729–736.
174. Ono K, Yonenobu K, Miyamoto S, et al. Pathology of ossification of the posterior longitudinal ligament and ligamentum flavum. Clin Orthop 1999;359:18–26.
175. Guo B, Jaovisidha S, Sartoris DJ, et al. Correlation between ossification of the stylohyoid ligament and osteophytes of the cervical spine. J Rheumatol 1997;24:1575–1581.
176. Cammisa M, De Serio A, Guglielmi G. Diffuse idiopathic skeletal hyperostosis. Eur J Radiol 1998;27[Suppl 1]:S7–S11.
177. Pappone N, Di Girolamo C, Del Puente A, et al. Diffuse idiopathic skeletal hyperostosis (DISH): a retrospective analysis. Clin Rheumatol 1996;15:121–124.
178. Resnick D, Niwayama G. Diffuse idiopathic hyperostosis (DISH) (ankylosing hyperostosis of Forestier and Rotes-Querol). In: Resnick D, ed. Diagnosis of bone and joint disorders, 3rd ed. Philadelphia: WB Saunders, 1995:1463–1495.
179. Kiss C, Szilagyi M, Paksy A, et al. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 2002;41:27–30.
180. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis-insulin, insulin-like growth factor I, growth hormone. J Rheumatol 1994;21: 1725–1730.
181. Schlapbach P, Beyeler C, Gerber NJ, et al. The prevalence of palpable finger joint nodules in diffuse idiopathic skeletal hyperostosis (DISH). A controlled study. Br J Rheumatol 1992;31:531–534.
182. Okawa A, Goto S, Moriya H. Calcitonin simultaneously regulates both periosteal hyperostosis and trabecular osteopenia in the spinal hyperostotic mouse (twy/twy) in vivo. Calcif Tissue Int 1999;64: 239–247.
183. Boushey DR, Bland JH. Pathology. In: Bland JH, ed. Disorders of the cervical spine. Philadelphia: WB Saunders,1987:64–73.
184. Tsuyama N. Ossification of the posterior longitudinal ligament of the spine. Clin Orthop 1984;184:71–84.
185. Ogata N, Koshizuka Y, Miura T, et al. Association of bone metabolism regulatory factor gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity. Spine 2002;27:1765–1771.
186. Irlenbusch V, Dominick G. [Examination of Heberden arthrosis with a histological-histochemical score]. Z Orthop Ihre Grenzgeb 1999; 137:355–361.
187. Cicuttini FM, Baker J, Hart DJ, et al. Relation between Heberden’s nodes and distal interphalangeal joint osteophytes and their role as markers of generalized disease. Ann Rheum Dis 1998;57:246–248.
188. Segal R, Avrahami E, Lebdinski E, et al. The impact of hemiparalysis on the expression of osteoarthritis. Arthritis Rheum 1998;41:2249–2256.
189. Nakamura R, Ono Y, Horii E, et al. The aetiological significance of workload in the development of osteoarthritis of the distal interphalangeal joint. J Hand Surg [Br] 1993;18:540–542.
190. Olejarova M, Kupka K, Pavelka K, et al. Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis. Results of a two-year study. J Bone Spine 2000;67:107–112.
191. Verbruggen G, Vey EM. Erosive and non-erosive hand osteoarthritis. Use and limitations of two scoring systems. Osteoarthritis Cartilage 2000;8[Suppl A]:S45–554.
192. Kassimos DG, Shirlaw PJ, Choy H, et al. Chronic sialadenitis in patients with nodal osteoarthritis. Br J Rheumatol 1997;36:1312–1317.
193. Nakamura M, Murakami G, Isogai S, et al. Regional specificity in degenerative changes in finger joints: an anatomical study using cadavers of the elderly. J Orthop Sci 2001;6:403–413.
194. Hirsch R, Lethbridge-Cejku M, Hanson R, et al. Familial aggregation of osteoarthritis: data from the Baltimore Longitudinal Study on Aging. Arthritis Rheum 1998;41:1227–1232.
195. Hirsch R, Lethbridge-Cejku M, Scott WW, et al. Association of hand and knee osteoarthritis: evidence for a polyarticular disease subset. Ann Rheum Dis 1996;55:25–29.
196. Riyazi N, Spee J, Huizinga TW, et al. HLA class II is associated with distal interphalangeal osteoarthritis. Ann Rheum Dis 2003;62:227–230.
197. Moos V, Menard J, Sieper J, et al. Association of HLA-DRB1*02 with osteoarthritis in a cohort of 106 patients. Rheumatology (Oxford) 2002;41:666–669.
198. Ushiyama T, Ueyama H, Inoue K, et al. Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol 1998;25:134–137.
199. Leppavuori J, Kujala U, Kinnunen J, et al. Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for locus on 2q. Am J Hum Genet 1999;65:1060–1067.
200. Felson DT, Couropmitree NN, Chaisson CE, et al. Evidence for a mendelian gene in segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum 1998;41: 1064–1071.
201. Jonsson H, Manolescu J, Stefansson SE, et al. The inheritance of hand osteoarthritis in Iceland. Arthritis Rheum 2003;48:391–395.
202. Knowlton RG, Katzenstein PL, Moskowitz RW, et al. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med 1990;332:526–530.
203. Reginato AJ, Passano GM, Neumann G, et al. Familial spondyloepiphyseal dysplasia tarda, brachydactyly, and precocious osteoarthritis associated with an arginine T5 cysteine mutation in the procollagen type II gene in a kindred of Chiloe islanders. Arthritis Rheum 1994; 37:1078–1086.
204. Pun YL, Moskowitz RW, Lie S, et al. Clinical correlations of osteoarthritis associated with a single-base mutation (arginine 519 to cysteine in type II procollagen gene: a newly defined pathogenesis. Arthritis Rheum 1994;37:264–269.
205. Bleasel JF, Bisagni-Faure A, Holderbaum D, et al. Type II procollagen gene (COL2A1) mutation in exon II associated with spondyloepiphyseal dysplasia, tall stature, and precocious osteoarthritis. J Rheumatol 1995;22:255–261.
206. Eyre DR, Weis MA, Moskowitz RW. Cartilage expression of a type II collagen mutation in an inherited form of osteoarthritis associated with a mild chondrodysplasia. J Clin Invest 1991;87:357–361.
207. Fertala A, Sieron AL, Adachi E, et al. Collagen II containing a Cys substitution for Arg-alpha 1–519: abnormal interactions of the mutated molecules with collagen IX. Biochemistry 2001;48:14422–14428.
208. Vikkula M, Palotie A, Ritvaniemi P, et al. Early onset osteoarthritis linked to the type II procollagen gene: detailed clinical phenotype and further analyses of the gene. Arthritis Rheum 1993;36:401–409.
209. Arita M, Li SW, Kopen G, et al. Skeletal abnormalities and ultrastructural changes of cartilage in transgenic mice expressing a collagen II gene (COL2A1) with Cys for ARg-alpha 1–219 substitution. Osteoarthritis Cartilage 2002;10:808–815.
210. Doherty M. Genetics of hand osteoarthritis. Osteoarthritis Cartilage 2000;8[Suppl A]:S8–510.
211. Loughlin J, Irven C, Fergusson C, et al. Sibling pair analysis shows no linkage of generalized osteoarthritis to the loci encoding type II collagen, cartilage link protein or cartilage matrix protein. Br J Rheumatol 1994;33:1103–1106.
212. Loughlin J, Irven C, Athanasou N, et al. Differential allelic expression of the type II collagen gene (COL2A1) in osteoarthritic cartilage. Am J Hum Genet 1995;56:1186–1193.
213. Broberg K, Hoglund M, Lindstrand A, et al. Polyclonal expansion of cells with trisomy 7 in synovia from patients with osteoarthritis. Cytogenet Cell Genet 1998;83:30–34.
214. Janocha S, Wolz W, Srsen S, et al. The human gene for alkaptonuria (AKU) maps to chromosome 3q. Genomics 1994;19:5–8.
215. Hamdi N, Cooke TD, Hassan B. Ochronotic arthropathy: case report and review of the literature. Int Orthop 1999;23:122–125.
216. Kabasakal Y, Kiyici I, Ozmen D, et al. Spinal abnormalities similar to ankylosing spondylitis in a 58-year-old woman with ochronosis. Clin Rheumatol 1995;14:355–357.
217. Aliberti G, Proietta M, Pulignano I, et al. HLA antigens in alkaptonuric patients. Panminerva Med 2001;43:145–148.
218. Stiehl P, Kluger KM. [Joint effusion findings in alkaptonuric arthropathy]. Z Rheumatol 1994;53:150–154.
219. Melis M, Onori P, Aliberti G, et al. Ochronotic arthropathy: structural and ultrastructural features. Ultrastruct Pathol 1994;18:467–471.
220. Hegedus ZL, Nayak U. Homogentisic acid and structurally related compounds as intermediates in plasma soluble melanin formation and in tissue toxicities. Arch Int Physiol Biochim Biophys 1994; 102:175–181.
221. Hiraku Y, Yamasaki M, Kawanishi S. Oxidative DNA damage included by homogentisic acid, a tyrosine metabolite. FEBS Lett 1998; 432:13–16.
222. Pascual E. Persistence of monosodium urate crystals and low grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 1991;34:141–145.
223. Pascual E, Battle-Gualda E, Martinez A, et al. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999;131: 756–759.
224. Sokoloff L. The history of Kashin-Beck disease. N Y State J Med 1989;89:343–351.
225. Mathieu F, Begaux F, Lan ZY, et al. Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet. Int Orthop 1997;21: 151–156.
226. Yu W, Wang Y, Jiang Y, et al. Kashin-Beck disease in children: radiographic findings in the wrist. Skeletal Radiol 2002;31:222–225.
227. Hinsenkamp M, Ryppens F, Begaux F, et al. The anatomical distribution of radiological abnormalities in Kashin-Beck disease in Tibet. Int Orthop 2001;25:142–146.
228. Moreno-Reyes R, Suetens C, Mathieu F, et al. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 1998;339:1112–1120.
229. Yang C, Niu C, Bodo M, et al. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular effects of Kashin-Beck disease. Biochem J 1993;289:829–835.
230. Zhang WH, Neve J, Xu JP, et al. Selenium, iodine, and fungal contamination in Yulin District (People’s Republic of China) endemic for Kashin-Beck disease. Int Orthop 2001;25:188–190.
231. Yang C, Bodo M, Holger N, et al. Fulvic acid disturbs processing of procollagen II in articular cartilage of embryonic chicken and may also cause Kashin-Beck disease. Eur J Biochem 1991;202:1141–1146.
232. Liang HJ, Tsai CL, Lu FJ. Oxidative stress induced by humic acid solvent extraction fraction in cultured rabbit articular chondrocytes. J Toxicol Environ Health 1998;54:477–489.
233. Sudre P, Mathieu F. Kashin-Beck disease: from etiology to prevention or from prevention to etiology? Int Orthop 2001;25:175–179.
234. Viljoen D, Fredlund V, Ramesar R, et al. Brachydactylous dwarfs of Mseleni. Am J Med Genet 1993;46:636–640.
235. Ballo R, Viljoen D, Machadu M, et al. Mseleni joint disease—a molecular genetic approach to defining the aetiology. S Afr Med J 1996; 86:956–958
236. Adebajo AO. Pattern of osteoarthritis in a West African teaching hospital. Ann Rheum Dis 1991;50:20–22.
237. Agarwal SS, Phadke SR, Fredlund V, et al. Mseleni and Handigodu familial osteoarthropathies. Syndromic identity? Am J Med Genet 1997;72:435–439.
238. Dhariwal AC, Bhattacharjee J, Sharma RS. “Handigodu disease: a disease of unknown etiology”–revisited. J Commun Dis 1998;30: 193–196.
239. Roosendaal G, van Rinsum AC, Vianen ME, et al. Hemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 1999;34:144–153.
240. Roosendaal G, van den Berg HM, Lafeber FP, et al. [Pathology of synovitis and hemophilic arthropathy]. Orthopade 1999;28:323–328.
241. Roosendaal G, Tekoppele JM, Vianen ME, et al. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999;42:1033–1039.
242. Yang SS. The skeletal system. In: Wigglesworth JS, Singer DB, eds. Textbook of fetal and perinatal pathology, 2nd ed. London: Blackwell, 1998:1039–1068.
243. Kocher MS, Shapiro F. Osteogenesis imperfecta. J AM Acad Orthop Surg 1998;6:225–236.
244. Giunta C, Superti-Furga A, Spranger S, et al. Ehlers-Danlos syndrome type VII: clinical features and molecular defects. J Bone Joint Surg 1999;81A:225–238.
245. Vujic M, Hallstensson, Wahlstrom J, et al. Localization of a gene for autosomal dominant Larsen syndrome to chromosome region 3 p21.1–14.1 in the proximity of, but distinct from the COL 7A1 locus. Am J Hum Genet 1995;57:1104–1113.
246. Hadley NA, Brown TD, Weinstein SL. The effects of contact pressure elevations and aseptic necrosis on the longterm outcome of congenital hip dislocation. J Orthop Res 1990;8:504–513.
247. Andersson JE. Neonatal hip instability: results and experiences from ten years of screening with the anterior-dynamic ultrasound method. Acta Paediatr 2002;91:929–929.
248. Tredwell SJ. Neonatal screening for hip joint instability. Clin Orthop 1992;281:63–68.
249. Lapunzina P, Camelo JS, Rittler M, et al. Risks of congenital anomalies in large for gestational age infants. J Pediatr 2002;140:200–204.
250. Hod M, Merlob P, Friedman S, et al. Prevalence of congenital anomalies and neonatal complications in the offspring of diabetic mothers in Israel. Isr J Med Sci 1991;27:498–502.
251. Granchi D, Stea S, Sudanese A, et al. Association of two gene polymorphisms with osteoarthritis secondary to hip dysplasia. Clin Orthop 2002;403:108–117.
252. Sollazzo V, Bertolani G, Calzolari E, et al. A two-locus model for non-syndromic congenital dysplasia of the hip (CDH). Ann Hum Genet 2000;64:51–59.
253. Todhunter RJ, Acland GM, Olivier M, et al. An outcrossed canine pedigree for linkage analysis of hip dysplasia. J Hered 1999;90:83–92.
254. Guille JT, Lipton GE, Szoke G, et al. Legg-Calvé-Perthes disease in girls. A comparison of the results with those seen in boys. J Bone Joint Surg Am 1998;80A:1256–1263.
255. Weinstein SL. Natural history and treatment outcomes of childhood hip disorders. Clin Orthop 1997;344:227–242.
256. Serafin J, Szulc W. Coxa vara infantum, hip growth disturbances, etiopathogenesis, and long-term results of treatment. Clin Orthop 1991;272:103–113.
257. Lane WE, Neuitt MC, Cooper C, et al. Acetabular dysplasia and osteoarthritis of the hip in elderly white women. Ann Rheum Dis 1997;56:627–630.
258. Smith RW, Egger P, Coggon D, et al. Osteoarthritis of the hip joint and acetabular dysplasia in women. Ann Rheum Dis 1995;54:179–181.
259. Koczewski P, Napiontek M. Perthes’ disease or late avascular necrosis after developmental dislocation of the hip? 10 Children followed for 6–35 years. Acta Orthop Scand 2001;72:331–334
260. Kruczynski J. Avascular necrosis of the proximal femur in developmental dislocation of the hip. Incidence, risk factors, sequelae and MR imaging for diagnosis and prognosis. Acta Orthop Scand 1996; 268[Suppl]:1–48.
261. Hochbergs P, Eckerwall G, Egund N, et al. Synovitis in Legg-Calvé-Perthes disease. Evaluation with MR imaging in 84 hips. Acta Radiol 1998;39:532–537.
262. Arruda VR, Belangero WD, Ozelo MC, et al. Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease. J Pediatr Orthop 1999;19:84–87.
263. Posan E, Szepesi K, Gaspar L, et al. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis 2003;14:243–248.
264. Stasikelis PJ, Sullivan CM, Phillips WA, et al. Slipped capital femoral epiphysis. Prediction of contralateral involvement. J Bone Joint Surg Am 1996;78A:1149–1155.
265. Maneatis T, Baptista J, Connelly K, et al. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000;13[Suppl 2]:1035–1044.
266. Goodman DA, Feighan JE, Smith AD, et al. Subclinical slipped capital femoral epiphysis. Relationship to osteoarthrosis of the hip. J Bone Joint Surg Am 1997;79A:1489–1497.
267. al-Rawi Z, Nessan AH. Joint hypermobility in patients with chondromalacia patellae. Br J Rheumatol 1997;36:1324–1327.
268. Gupta R. A short history of neuropathic arthropathy. Clin Orthop 1993;296:43–49.
269. Squeira W. The neuropathic joint. Clin Exp Rheumatol 1994;12:325–327.
270. Sharma L, Pai Y-C, Holtkamp K, et al. Is knee joint proprioception worse in the arthritic knee versus the unaffected knee in unilateral knee osteoarthritis. Arthritis Rheum 1997;40:1518–1525.
271. Steinberg ME, Corces A, Fallon M. Acetabular involvement in osteonecrosis of femoral head. J Bone Joint Surg Am 1999;81A:60–65.
272. Jones JP. Coagulopathies and osteonecrosis. Acta Orthop Belg 1999; 65[Suppl 1]:5–8.
273. Muscolo DL, Costa-Paz M, Makino A, et al. Osteonecrosis of the knee following arthroscopic meniscectomy in patients over 50 years old. Arthroscopy 1996;12:273–279.
274. Vingard E, Alfredsson L, Malchau H. Osteoarthritis of the hip in women and its relation to physical load at work and in the home. Ann Rheum Dis 1997;56:293–298.
275. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41: 1343–1355.
276. Gunther KP, Puhl W, Brenner H, et al. [Clinical epidemiology of hip and knee joint arthroses: an overview of the results of the “Ulm Osteoarthrosis Study.”] Z Rheumatol 2002;61:244–249.
277. Axford JS, Bomford A, Revell P, et al. Hip arthropathy in genetic hemochromatosis. Radiographic and histologic features. Arthritis Rheum 1991;34:357–361.
278. Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am 1996;25:473–483.
279. Sturmer T, Brenner H, Brenner RE, et al. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Scand J Rheumatol 2001;30:169–171.
280. Cimmino MA, Cutolo M. Plasma glucose concentration in symptomatic osteoarthritis. A clinical and epidemiological survey. Clin Exp Rheumatol 1990;8:251–257.
281. Frey MI, Barrett-Connor E, Sledge PA, et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996;23:716–722.
282. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, et al. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford) 2002;41:1155–1162.
283. Sharma L. The epidemiology of osteoarthritis. In: Moskowitz RW, Howell DS, Altman RD, et al. Osteoarthritis: diagnosis and medical/ surgical management, 3rd ed. Philadelphia: WB Saunders, 2001: 3–27.
284. Belmonte-Serrano MA, Block DA, Lane NE, et al. The relationship between spinal and peripheral osteoarthritis and bone density measurements. J Rheumatol 1993;20:1005–1013.
285. Ito M, Hayashi K, Yamada M, et al. Relationship of osteophytes to bone mineral density and spinal fracture in men. Radiology 1993; 189:497–502.
286. Dequeker J, Mohan S, Finkelman RD, et al. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from iliac crest. Arthritis Rheum 1993;36:1702–1708.
287. Raymackers G, Aerssens J, Van der Eynde R, et al. Alterations of the mineralization profile and osteocalcin concentrations in osteoarthritic cortical iliac crest bone. Calcif Tissue Int 1992;51:269–275.
288. Pullig O, Weseloh G, Ronneberger D, et al. Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 2000;67:230–240.
289. Keen RW, Hart DJ, Lanchbury JS, et al. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum 1997;40:1444–1449.
290. Meulenbelt I, Bijerk C, de Wildt SC, et al. Investigation of the association of the CRTM and CRTL1 genes with radiographically evident osteoarthritis in subjects from the Rotterdam study. Arthritis Rheum 1997;40:1760–1765.
291. Spector TD, Cicuttini F, Baker J, et al. Genetic influences on osteoarthritis in women: a twin study. Br Med J 1996;312:940–943.
292. Muragaki Y, Mariman ECM, van Beersum SEC, et al. A mutation in the gene encoding the a2 chain of the fibril-associated collagen IX, COL9A2 causes multiple epiphyseal dysplasia (EDM2). Nat Genet 1996;12:103–105.
293. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 1999;42:17–24.
294. Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996;23:1221–1226.
295. Cerhan JR, Wallace RB, el-Khoury GY, et al. Decreased survival with increasing prevalence of full-body radiographically defined osteoarthritis in women. Am J Epidemiol 1995;141:225–234.
296. Roach KE, Persky V, Miles T, et al. Biomechanical aspects of occupation and osteoarthritis of the hip: a case-control study. J Rheumatol 1994;21:2334–2340.
297. Dewire P, Einhorn TA. The joint as an organ. In: Moskowitz RW, Howell DS, Altman RD, et al. Osteoarthritis: diagnosis and medical/ surgical management, 3rd ed. Philadelphia: WB Saunders, 2001:49–68.
298. Jay GD, Britt DE, Cha CJ. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol 2000;27:594–600.
299. Schwarz IM, Hills BA. Synovial surfactant: lamellar bodies in type B synoviocytes and proteolipid in synovial fluid and the articular lining. Br J Rheumatol 1996;35:821–827.
300. Schwarz IM, Hills BA. Surface-active phospholipid as the lubricating component of lubricin. Br J Rheumatol 1998;37:21–26.
301. Jay GD, Cha CJ. The effect of phospholipase digestion upon the boundary lubricating ability of synovial fluid. J Rheumatol 1999;26: 2454–2457.
302. Hills BA, Monds MK. Deficiency of lubricating surfactant lining the articular surfaces of replaced hips and knees. Br J Rheumatol 1998; 37:143–147.
303. Woo SL-Y, Fenwick JA, Kanamori A, et al. Biomechanical considerations of joint function. In: Moskowitz RW, Howell DS, Altman RD, et al. Osteoarthritis: diagnosis and medical/surgical management, 3rd ed. Philadelphia: WB Saunders, 2001:145–169.
304. Helliwell PS. Osteoarthritis and Paget’s disease. Br J Rheumatol 1995;34:1061–1063.